Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.
Adaptive Immunity
Alopecia
/ congenital
Case-Control Studies
Cohort Studies
Cytochrome P-450 CYP1B1
/ genetics
Female
Gene Expression
Genetic Loci
Genetic Predisposition to Disease
Genome, Human
Genome-Wide Association Study
HLA-B7 Antigen
/ genetics
Humans
Immunity, Innate
Polymorphism, Single Nucleotide
Transcriptome
/ immunology
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
08 03 2019
08 03 2019
Historique:
received:
01
08
2018
accepted:
13
02
2019
entrez:
10
3
2019
pubmed:
10
3
2019
medline:
4
4
2019
Statut:
epublish
Résumé
Frontal fibrosing alopecia (FFA) is a recently described inflammatory and scarring type of hair loss affecting almost exclusively women. Despite a dramatic recent increase in incidence the aetiopathogenesis of FFA remains unknown. We undertake genome-wide association studies in females from a UK cohort, comprising 844 cases and 3,760 controls, a Spanish cohort of 172 cases and 385 controls, and perform statistical meta-analysis. We observe genome-wide significant association with FFA at four genomic loci: 2p22.2, 6p21.1, 8q24.22 and 15q2.1. Within the 6p21.1 locus, fine-mapping indicates that the association is driven by the HLA-B*07:02 allele. At 2p22.1, we implicate a putative causal missense variant in CYP1B1, encoding the homonymous xenobiotic- and hormone-processing enzyme. Transcriptomic analysis of affected scalp tissue highlights overrepresentation of transcripts encoding components of innate and adaptive immune response pathways. These findings provide insight into disease pathogenesis and characterise FFA as a genetically predisposed immuno-inflammatory disorder driven by HLA-B*07:02.
Identifiants
pubmed: 30850646
doi: 10.1038/s41467-019-09117-w
pii: 10.1038/s41467-019-09117-w
pmc: PMC6408457
doi:
Substances chimiques
HLA-B*07:02 antigen
0
HLA-B7 Antigen
0
CYP1B1 protein, human
EC 1.14.14.1
Cytochrome P-450 CYP1B1
EC 1.14.14.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1150Subventions
Organisme : Department of Health
ID : CDF-2014-07-037
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S003126/1
Pays : United Kingdom
Références
Br J Dermatol. 2010 May;162(5):1154-5
pubmed: 20128789
J Pathol. 2013 Oct;231(2):236-47
pubmed: 23788005
Cancer Lett. 2015 Jan 28;356(2 Pt A):231-43
pubmed: 24784887
Pharmacol Ther. 2013 Apr;138(1):103-41
pubmed: 23333322
Sci Rep. 2017 Mar 09;7:44005
pubmed: 28276465
Nat Genet. 2015 Mar;47(3):291-5
pubmed: 25642630
Mol Pharmacol. 2005 Feb;67(2):435-43
pubmed: 15486049
Exp Dermatol. 2016 Nov;25(11):847-852
pubmed: 27198858
Nucleic Acids Res. 2018 Jul 2;46(W1):W486-W494
pubmed: 29762782
J Am Acad Dermatol. 2010 Oct;63(4):653-60
pubmed: 20846567
J Am Acad Dermatol. 2014 Nov;71(5):e208-10
pubmed: 25437995
J Cheminform. 2010 Oct 18;2(1):9
pubmed: 20955607
J Am Acad Dermatol. 2014 Apr;70(4):670-678
pubmed: 24508293
Hum Immunol. 2013 Oct;74(10):1333-8
pubmed: 23916976
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
pubmed: 12824425
J Investig Dermatol Symp Proc. 2003 Oct;8(2):188-94
pubmed: 14582671
Nat Genet. 2014 Jun;46(6):543-550
pubmed: 24816252
Indian J Dermatol Venereol Leprol. 2015 Mar-Apr;81(2):162-5
pubmed: 25751333
Br J Dermatol. 2013 Jan;168(1):220-2
pubmed: 22716508
Metabolism. 2001 Sep;50(9):1001-3
pubmed: 11555828
PLoS Genet. 2014 May 15;10(5):e1004383
pubmed: 24830394
J Biol Chem. 1988 Oct 15;263(29):15146-50
pubmed: 2971663
Bioinformatics. 2017 Feb 1;33(3):447-449
pubmed: 28171615
Br J Dermatol. 2016 Oct;175(4):762-7
pubmed: 26987767
Dermatol Ther. 2018 Nov;31(6):e12656
pubmed: 30264512
Pharmacol Ther. 2017 Oct;178:18-30
pubmed: 28322972
Genet Epidemiol. 2009 Jan;33(1):79-86
pubmed: 18642345
Am J Hum Genet. 2011 Jan 7;88(1):76-82
pubmed: 21167468
Genome Biol. 2010;11(3):R25
pubmed: 20196867
Bioinformatics. 2012 Apr 15;28(8):1114-21
pubmed: 22355083
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
AIDS Res Hum Retroviruses. 2014 May;30(5):468-75
pubmed: 24010680
Eur J Med Chem. 2017 Jul 28;135:296-306
pubmed: 28458135
Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):89-104
pubmed: 14574440
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Curr Drug Metab. 2014;15(9):893-914
pubmed: 25658124
Blood. 2003 Nov 1;102(9):3287-94
pubmed: 12869499
Nat Genet. 2012 Dec;44(12):1294-301
pubmed: 23104008
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
J Am Acad Dermatol. 2018 Jan;78(1):e21-e22
pubmed: 29241802
J Invest Dermatol. 2018 Sep;138(9):1911-1916
pubmed: 30057345
PLoS One. 2013 Jun 06;8(6):e64683
pubmed: 23762245
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
Mol Cell Biol. 2007 Feb;27(3):1096-111
pubmed: 17101770
Endocrinology. 2003 Aug;144(8):3382-98
pubmed: 12865317
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
J Am Acad Dermatol. 2015 Jul;73(1):e37
pubmed: 26089074
J Cosmet Dermatol. 2015 Mar;14(1):64-9
pubmed: 25614294
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Immunity. 2000 Mar;12(3):273-83
pubmed: 10755614
Arch Dermatol. 1994 Jun;130(6):770-4
pubmed: 8002649
Br J Dermatol. 2008 Nov;159(5):1077-85
pubmed: 18795933